Skip to main content
. 2021 Nov 8;11:21879. doi: 10.1038/s41598-021-01305-3

Table 2.

Dosimetry comparison for the OAR of RP group and NP group (mean ± SD) (cGy).

OAR n RP group NP group t P
Ipsilateral lung V20Gy 50 19.56 ± 2.4 22.1 ± 2.06 − 6.15 0.00b
V10Gy 50 31.01 ± 3.06 32.16 ± 2.84 − 4.20 0.00b
V5Gy 50 45.83 ± 4.56 44.9 ± 3.48 2.38 0.02a
Dmean 50 10.68 ± 1.09 11.45 ± 1.02 − 6.14 0.00b
Heart Dmean 50 4.95 ± 1.72 5.38 ± 1.88 − 3.68 0.01a
Breast-R Dmean 50 11.19 ± 7.17 17.27 ± 12 − 4.79 0.00b
Spinal cord Dmax 50 13.62 ± 3.16 22.67 ± 5.7 − 6.02 0.00b
shoulder joint-L Dmean 50 7.93 ± 2.2 12.38 ± 2.53 − 15.34 0.00a
Dmax 50 20.06 ± 7.84 32.63 ± 7.74 − 13.71 0.00a
Thyroid Dmean 50 15.25 ± 4.82 14.6 ± 4.93 − 1.38 0.17b
Dmax 50 47.26 ± 8.9 45.47 ± 7.89 − 3.66 0.00b
Trachea Dmean 50 6.79 ± 2.04 7.51 ± 3.25 − 2.48 0.02a
Dmax 50 19.83 ± 8.46 22.85 ± 10.11 − 4.02 0.00a
Esophagus Dmean 50 3.94 ± 1.88 4.3 ± 2.55 − 1.68 0.01b
Dmax 50 28.89 ± 12.76 30.78 ± 12.41 − 2.06 0.05a
Intestines Dmean 50 7.59 ± 5.85 12.46 ± 10.89 − 4.53 0.00b
Dmax 50 32.58 ± 19.06 36.84 ± 18.78 − 2.15 0.03b

*a = Paired t test, *b = Nonparametric Wilcoxon test, P < 0.05.

Bold values indicates that the difference is statistically significant (P<0.05)